Cryoport, Inc. (CYRX)
Chart Events
Performance Outlook
| Previous Close | 24.78 |
| Open | 24.20 |
| Bid | 24.04 x 1800 |
| Ask | 24.12 x 900 |
| Day's Range | 23.16 - 24.63 |
| 52 Week Range | 19.82 - 86.30 |
| Volume | |
| Avg. Volume | 419,134 |
| Market Cap | 1.186B |
| Beta (5Y Monthly) | 1.11 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.95 |
| Earnings Date | Nov 02, 2022 - Nov 07, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 52.00 |
- PR Newswire
Cryoport Enters into Strategic Relationship with Takeda's BioLife Plasma Services
Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences industry, today announced it has entered into a strategic relationship with BioLife Plasma Services, part of the global biopharmaceutical company Takeda, intended to provide consistent, high-quality cellular starting material for use in the manufacture of life-saving cellular therapies.
- Investor's Business Daily
Cryoport Stock Shows Market Leadership With Jump To 91 RS Rating
On Monday, Cryoport stock hit an important technical milestone, with its Relative Strength (RS) Rating rising into the 90-plus percentile with an upgrade to 91, a rise from 82 the day before. Is Cryoport Stock A Buy? On Monday, Cryoport stock retook its 200-day moving average.
- Simply Wall St.
Cryoport, Inc.'s (NASDAQ:CYRX) Profit Outlook
With the business potentially at an important milestone, we thought we'd take a closer look at Cryoport, Inc.'s...
